Ras (KRAS or NRAS) Gene Mutation

Explore clinical trials studying Ras (KRAS or NRAS) Gene Mutation. Study availability and eligibility vary by location and protocol.

4 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Ras (KRAS or NRAS) Gene Mutation trial results

Recruiting

NCT06326411

Conditions: Glioma, MAPK Pathway Gene Mutation, MEK Mutation, +19 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

UCLA Hematology/Oncology Westwood, Los Angeles, California, United States

Sarah Cannon Research Institute at Health ONE Denver, Colorado, United States

Yale Cancer Center New Haven, Connecticut, United States

View all 23 locations

Recruiting

NCT04151342

Conditions: Cancer, Cancer, Therapy-Related, Congenital Abnormalities, +11 more
Locations: Tom Baker Cancer Centre - University of Calgary - Alberta Health Services Calgary, Alberta, Canada

Cross Cancer Institute, University of Alberta - Alberta Health Services Edmonton, Alberta, Canada

BC Cancer Vancouver, British Columbia, Canada

CancerCare Manitoba/University of Manitoba Winnipeg, Manitoba, Canada

View all 27 locations

Recruiting

NCT06449989

Conditions: BRAF Gene Mutation, Brain Diseases, Brain Metastases, Adult, +11 more
Locations: Blokhin's Russian Cancer Research Center Moscow, Russia

Recruiting

NCT06229340

Conditions: Colonic Diseases, Colorectal Cancer Recurrent, Colorectal Neoplasms, +33 more
Locations: Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation Saint Petersburg, Russia